2nd Quarter - Report
WASHINGTON HEALTH STRATEGIES GROUP for ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
$30,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 26, 2016 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Nov 30, 2016 | $30,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures, Conduct of Clinical Trials, FDA, NIH, R&D Tax Credit, Corporate Tax Reform, Drug Safety, Innovation for Healthier Americans
| Lobbyist | Covered position, as disclosed |
|---|---|
| SABAH BHATNAGAR New | — |
| JOHN LEWIS | — |
| DOUGLAS PEDDICORD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.